Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Myoclonic Epilepsy of Infancy”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Not applicableStudy completedNCT03857451
What this trial is testing

Treatment of Gait Disorders in Children With Dravet Syndrome

Who this might be right for
Dravet SyndromeSevere Myoclonic Epilepsy of Infancy
Universiteit Antwerpen 50
Large-scale testing (Phase 3)WithdrawnNCT02174094
What this trial is testing

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Who this might be right for
Dravet Syndrome
H. Lundbeck A/S
Large-scale testing (Phase 3)WithdrawnNCT02318563
What this trial is testing

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome

Who this might be right for
Dravet Syndrome
INSYS Therapeutics Inc
Large-scale testing (Phase 3)Study completedNCT02091375
What this trial is testing

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 120
Testing effectiveness (Phase 2)Looking for participantsNCT06401538
What this trial is testing

BMB-101 in Absence Epilepsy and DEE

Who this might be right for
Absence EpilepsyJeavons SyndromeDravet Syndrome+1 more
Bright Minds Biosciences Pty Ltd 20
Early research (Phase 1)Study completedNCT02286986
What this trial is testing

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

Who this might be right for
Epilepsy
University of Utah 26
Testing effectiveness (Phase 2)Study completedNCT05626634
What this trial is testing

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

Who this might be right for
Developmental and Epileptic EncephalopathyDravet SyndromeLennox-Gastaut Syndrome
Longboard Pharmaceuticals 41
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Large-scale testing (Phase 3)Ended earlyNCT06422377
What this trial is testing

A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine

Who this might be right for
Dravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)
Takeda 1
Not applicableStudy completedNCT05982717
What this trial is testing

Gather Information About Overall Occurrence and New Cases of Dravet and Lennox-Gastaut Syndromes in Children, Teenagers and Adults in Spain

Who this might be right for
Dravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)
Takeda 237
Large-scale testing (Phase 3)Ended earlyNCT04572243
What this trial is testing

Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome

Who this might be right for
Epilepsies, Myoclonic
Eisai Inc. 22
Post-approval studies (Phase 4)Looking for participantsNCT06598449
What this trial is testing

Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age

Who this might be right for
Dravet Syndrome (DS)Children Under 2 Years
University of Colorado, Denver 5
Large-scale testing (Phase 3)Study completedNCT02926898
What this trial is testing

A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 87
Large-scale testing (Phase 3)Looking for participantsNCT06872125
What this trial is testing

Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Stoke Therapeutics, Inc 170
Large-scale testing (Phase 3)Study completedNCT03936777
What this trial is testing

Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

Who this might be right for
Dravet SyndromeLennox Gastaut SyndromeEpileptic Encephalopathy
Zogenix, Inc. 412
Testing effectiveness (Phase 2)Looking for participantsNCT05419492
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

Who this might be right for
Dravet Syndrome
Encoded Therapeutics 47
Large-scale testing (Phase 3)Ended earlyNCT05560282
What this trial is testing

Fenfluramine for Adult Dravet Patients

Who this might be right for
Dravet SyndromeDravet Syndrome, Intractable
University Health Network, Toronto 7
Not applicableLooking for participantsNCT05126914
What this trial is testing

Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents

Who this might be right for
EpilepsyWest SyndromeDravet Syndrome
Assistance Publique - Hôpitaux de Paris 1,000
Testing effectiveness (Phase 2)Study completedNCT01607073
What this trial is testing

Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Gillette Children's Specialty Healthcare 2
Large-scale testing (Phase 3)Study completedNCT02224703
What this trial is testing

GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 199
Load More Results